Over half of patients in a randomized trial switch from enzalutamide to darolutamide because of cognitive issues; no one switches in the opposite direction.

The FDA has approved datopotamab deruxtecan (Dato-DXd, Datroway, Daiichi Sankyo) for the treatment of patients with ...

The Fracture Risk Assessment Tool predictions suggest patients who don’t meet guideline criteria for parathyroidectomy may ...

Semaglutide and tirzepatide use is rising among patients with rheumatic and musculoskeletal diseases and is linked to meaningful 1-year weight loss, especially in tirzepatide users.

Emerging evidence suggests some sugar substitutes may affect metabolism, gut microbiome, and cardiovascular health more than ...

It was in the 1920s when a New Jersey pathologist first described what he called “punch-drunk syndrome,” a cluster of tremors, slowed movement, and speech difficulties seen in career boxers. Rebranded ...

A lightweight robotic knee device improves strength, muscle growth, and standing ability in children with SMA, with benefits ...

Pierre de Brémond d’Ars, a French GP who leads the evidence-based medicine group NoFakeMed, tells Medscape’s French edition ...

Higher dermatologist density is associated with lower proportions of late stage melanoma diagnosis across US health service ...

A European report says the WHO should urgently scale up climate and health action in the face of waning attention.

Participants on weekly injections of 12 mg retatrutide lost an average of 70.3 lbs (28.3%) over 80 weeks, and 45.3% of participants achieved ≥ 30% weight loss.

Specific serum acylcarnitine levels are linked to faster kidney function decline in type 2 diabetes and can help improve the ...